174 related articles for article (PubMed ID: 1860681)
21. Free and conjugated catecholamines in patients with cirrhosis.
Gaudin C; Braillon A; Selz F; Cuche JL; Lebrec D
J Lab Clin Med; 1990 May; 115(5):589-92. PubMed ID: 2341761
[TBL] [Abstract][Full Text] [Related]
22. Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol.
Snady H; Lieber CS
Am J Gastroenterol; 1988 Mar; 83(3):249-55. PubMed ID: 3344727
[TBL] [Abstract][Full Text] [Related]
23. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J
J Hepatol; 1987 Feb; 4(1):71-9. PubMed ID: 3033061
[TBL] [Abstract][Full Text] [Related]
24. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
25. Splanchnic and renal contribution to disposal of infused epinephrine in humans.
Saccà L; Hendler R; Picardi A; Sherwin RS
Am J Physiol; 1986 Sep; 251(3 Pt 1):E285-9. PubMed ID: 3752240
[TBL] [Abstract][Full Text] [Related]
26. Increased spillover of norepinephrine to the portal vein during CO-pneumoperitoneum in pigs.
Myre K; Rostrup M; Eriksen M; Buanes T; Raeder J; Stokland O
Acta Anaesthesiol Scand; 2004 Apr; 48(4):443-50. PubMed ID: 15025606
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of the contribution of hepatic, renal and portal circulation to the clearance of exogenous catecholamines.
Sumikawa K; Hirano H
Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):337-46. PubMed ID: 3175332
[TBL] [Abstract][Full Text] [Related]
28. Effects of propranolol on renal blood flow and renal function in patients with cirrhosis.
Bataille C; Bercoff E; Pariente EA; Valla D; Lebrec D
Gastroenterology; 1984 Jan; 86(1):129-33. PubMed ID: 6357936
[TBL] [Abstract][Full Text] [Related]
29. Renal contribution to plasma catecholamines--effect of age.
Kjeldsen SE; Eide I; Christensen C; Westheim A; Müller O
Scand J Clin Lab Invest; 1982 Sep; 42(5):461-6. PubMed ID: 7156858
[TBL] [Abstract][Full Text] [Related]
30. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
Hepatology; 1991 Sep; 14(3):483-7. PubMed ID: 1874493
[TBL] [Abstract][Full Text] [Related]
31. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
32. Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension.
Vlavianos P; Mac Mathuna P; Williams R; Westaby D
Clin Sci (Lond); 1999 May; 96(5):475-81. PubMed ID: 10209079
[TBL] [Abstract][Full Text] [Related]
33. Influence of beta blockade on branched chain amino acid concentrations in cirrhosis.
Eriksson LS; Söderman C
Hepatogastroenterology; 1992 Oct; 39(5):451-4. PubMed ID: 1459531
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
Braillon A; Calès P; Lebrec D
Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
[TBL] [Abstract][Full Text] [Related]
35. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis.
Henriksen JH; Ring-Larsen H; Kanstrup IL; Christensen NJ
Gut; 1984 Oct; 25(10):1034-43. PubMed ID: 6479678
[TBL] [Abstract][Full Text] [Related]
36. Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockade.
Bendtsen F; Gerbes AL; Henriksen JH
Scand J Clin Lab Invest; 1993 Oct; 53(6):547-54. PubMed ID: 8265999
[TBL] [Abstract][Full Text] [Related]
37. Reversal of adrenaline-induced increase in azygos blood flow in patients with cirrhosis receiving propranolol.
Valla D; Gaudin C; Geoffroy P; Braillon A; Lee SS; Lebrec D
J Hepatol; 1987 Feb; 4(1):86-92. PubMed ID: 3494761
[TBL] [Abstract][Full Text] [Related]
38. Effects of circulating catecholamines on hepatic blood volume in anesthetized cats.
Greenway CV; Dettman R; Burczynski F; Sitar DS
Am J Physiol; 1986 Jun; 250(6 Pt 2):H992-7. PubMed ID: 3717370
[TBL] [Abstract][Full Text] [Related]
39. Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis.
Braillon A; Gaudin C; Poo JL; Moreau R; Debaene B; Lebrec D
Hepatology; 1992 Jan; 15(1):58-62. PubMed ID: 1727800
[TBL] [Abstract][Full Text] [Related]
40. Release and clearance rates of epinephrine in man: importance of arterial measurements.
Best JD; Halter JB
J Clin Endocrinol Metab; 1982 Aug; 55(2):263-8. PubMed ID: 7085853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
